wanfang site visit

Hyperthermia is reemerging on to the cancer treatment stage. There is growing acceptance of hyperthermia's role as a radiosensitizer, its effectiveness when used with chemotherapy, and maybe its most important role, in immunomodulation.

Pyrexar Medical receives requests to introduce our hyperthermia systems into new countries every month. In 2015, we were selling in 9 countries, three years later the count has grown to well over 36 countries. But the road is long from introduction to sale and is often drawn-out with regulatory filings, physician education, toward eventual acceptance. That is why we are so thankful for physicians like Dr. Gi-Ming Lai, Director of the Wan Fang Cancer Center, and his team at the Taipei Municipal Wan Fang Hospital, part of the Taipei Medical University in Taiwan.

The clinical data for hyperthermia, and specifically the BSD-2000 Deep Regional Hyperthermia system, is very impressive. But potential customers often want to see a device in a treatment environment to understand workflow and treatment planning. So when a new distributor from the region requested to visit a reference site, we reached out to our partner network and Linden Bioscience of Taiwan answered the call.

"Wan Fang is a well respected center in Taiwan, and Dr. Lai's experience with hyperthermia is unparalleled in the region" says Tainang Huang, president of Linden Bioscience. "They have a well-outfitted radiation oncology department and a strong team in medical oncology under Dr. Lai's direction".  Wan Fang was the first JCI accredited hospital in Taiwan. The 730 bed facility has more than 350 full-time physicians, and over 2000 additional staff members. Because it is affiliated with Taipei Medical University, many doctors in training from the university complete internships at Wan Fang.

We believe with solid partnerships and a willingness to share knowledge, hyperthermia will continue to grow and serve cancer patients around the globe.

 

ASTRO's 60th Annual Meeting is the premier radiation oncology scientific event in the world and draws more than 11,000 attendees each year. This years exhibits will be held October 21-23th at the at the Henry B. Gonzalez Convention Center in downtown San Antonio, Texas (USA). Look for us in booth #1942.

ASTRO 2018 floorplan

We look forward to seeing you at the show. For more information visit the ASTRO website.

 


Pyrexar has signed with Kamol Sukosol Electric Company (KEC) to distribute Pyrexar's line of hyperthermia systems in Thailand. For over twenty years KEC has been supplying hospitals and clinics around the country with machinery vital in the fight against cancer. Their talented and well-trained sales and service group have started the process of introducing radiative phased array hyperthermia to their customers. Please join us in welcoming KEC to the Pyrexar family. We are fortunate to have such an excellent organization on our team. 

We were in Thailand in June to meet with Daranee Clapp, Executive VP of KEC, and her team to pitch the Pyrexar hyperthermia solution to several Bangkok area hospitals.  Below are a few photos of our visit.

THAI slideshow key


Kamol Sukosol Electric Company Background

KEC traces its roots back to 1939 when its president, Mr Kamol Sukosol, started the trading business with a shipment of twelve G.E. radio sets from the United States. Before too long the company grew to have 22 showrooms in Bangkok and its surrounding provinces. Less than a decade later, the company become G.E’s sole distributor in Thailand. With each passing year, new product lines were added and KEC’s scope of activities spread from household appliances to electrical and engineering equipment, air conditioning, motor vehicles, manufacturing and, most importantly, healthcare.  The company has a fascinating success story. You can read more here.

Pyrexar Medical was invited to participate in the Hanoi 2018 - Investment and Development Cooperation event. This year's event included twenty four MoUs (Memoranda of Understanding) and investment certificates at a total value of 270 trillion VND (approx. $12 billion USD). During the ceremony, Pyrexar received an award from the ministry of heath and signed an agreement to deliver hyperthermia systems to government hospitals this year.


Around 1,500 representatives, including leaders of the government, ministries, international organizations and hundreds of investors and businesses were in attendance. The conference is a chance for the Capital to meet domestic and foreign investors, representatives of embassies, and international organizations, to attract more domestic and foreign investments in Hanoi and the rest of the country.

A special thank you to our new distributor for Vietnam, Cambodia and Laos, Thai Thinh Medical of Hanoi City, for making this opportunity happen. The result; Pyrexar successfully signed agreements for placement of two BSD-500 Superficial Hyperthermia systems, a BSD-2000 Deep Regional Hyperthermia system and our newest BSD-2000 3D/MR Image Guided Thermal Therapy system to Hanoi High Tech and Digestive Center at St. Paul's Hospital and VinMec International Hospital, in Hanoi.